These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 5039550)

  • 1. Withdrawal depression in obese patients after fenfluramine treatment.
    Steel JM; Briggs M
    Br Med J; 1972 Jul; 3(5817):26-7. PubMed ID: 5039550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual effect of fenfluramine.
    Golding D
    Br Med J; 1970 Jan; 1(5690):238. PubMed ID: 5460561
    [No Abstract]   [Full Text] [Related]  

  • 3. Fenfluramine dependence.
    Harding T
    Br Med J; 1971 Jul; 3(5769):305. PubMed ID: 5557547
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs of dependence though not of abuse: fenfluramine and imipramine.
    Oswald I; Lewis SA; Dunleavy DL; Brezinova V; Briggs M
    Br Med J; 1971 Jul; 3(5766):70-3. PubMed ID: 5090822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bipolar depression associated with fenfluramine and phentermine.
    Zimmer JE; Gregory RJ
    J Clin Psychiatry; 1998 Jul; 59(7):383-4. PubMed ID: 9714271
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of three anorexiants. Clortermine hydrochloride (voranil), fenfluramine hydrochloride (pondimin), and mazindol (sanorex).
    Dykes MH
    JAMA; 1974 Oct; 230(2):270-2. PubMed ID: 4606535
    [No Abstract]   [Full Text] [Related]  

  • 7. Fenfluramine and phentermine.
    Shuster J
    Nursing; 1997 Feb; 27(2):69. PubMed ID: 9171612
    [No Abstract]   [Full Text] [Related]  

  • 8. Cerebral hemorrhage in a patient taking fenfluramine and phentermine for obesity.
    Wen PY; Feske SK; Teoh SK; Stieg PE
    Neurology; 1997 Aug; 49(2):632-3. PubMed ID: 9270617
    [No Abstract]   [Full Text] [Related]  

  • 9. Echocardiographic improvement over time after cessation of use of fenfluramine and phentermine.
    Hensrud DD; Connolly HM; Grogan M; Miller FA; Bailey KR; Jensen MD
    Mayo Clin Proc; 1999 Dec; 74(12):1191-7. PubMed ID: 10593346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of multivalvular regurgitation after the cessation of fenfluramine and phentermine treatment.
    Cannistra LB; Cannistra AJ
    N Engl J Med; 1998 Sep; 339(11):771. PubMed ID: 9742026
    [No Abstract]   [Full Text] [Related]  

  • 11. Valvular heart disease in fenfluramine- phentermine-treated patients: a comparison with control patients.
    Wadden TA; Silvestry FE; Aber JL; Berkowitz RI; Foster GD; Sutton MG
    Obes Res; 1999 May; 7(3):309-10. PubMed ID: 10348504
    [No Abstract]   [Full Text] [Related]  

  • 12. A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation.
    Jick H; Vasilakis C; Weinrauch LA; Meier CR; Jick SS; Derby LE
    N Engl J Med; 1998 Sep; 339(11):719-24. PubMed ID: 9731087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenfluramine and phentermine.
    Howlin D
    Ann Intern Med; 2001 Nov; 135(9):840-1. PubMed ID: 11694113
    [No Abstract]   [Full Text] [Related]  

  • 14. The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs.
    Khan MA; Herzog CA; St Peter JV; Hartley GG; Madlon-Kay R; Dick CD; Asinger RW; Vessey JT
    N Engl J Med; 1998 Sep; 339(11):713-8. PubMed ID: 9731086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anorectic-induced valvulopathy.
    Cheng TO
    Eur Heart J; 2000 Apr; 21(7):593-4. PubMed ID: 10775015
    [No Abstract]   [Full Text] [Related]  

  • 16. Obesity and an abnormal ECG.
    Hancock EW
    Hosp Pract (1995); 1997 Sep; 32(9):19-20. PubMed ID: 9307592
    [No Abstract]   [Full Text] [Related]  

  • 17. In search of a 'magic' pill to treat obesity: the rise and fall of 'Fen-Phen'.
    Capriotti T
    Medsurg Nurs; 1998 Feb; 7(1):52-4. PubMed ID: 9544011
    [No Abstract]   [Full Text] [Related]  

  • 18. Appetite suppressants and valvular heart disease.
    Devereux RB
    N Engl J Med; 1998 Sep; 339(11):765-6. PubMed ID: 9731094
    [No Abstract]   [Full Text] [Related]  

  • 19. Unusual effect of fenfluramine.
    Imlah NW
    Br Med J; 1970 Apr; 2(5702):178-9. PubMed ID: 5440606
    [No Abstract]   [Full Text] [Related]  

  • 20. Diet pills redux.
    Curfman GD
    N Engl J Med; 1997 Aug; 337(9):629-30. PubMed ID: 9271487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.